Genetic and immunophenotypic diversity of acute leukemias in children

[1] de Rooij JD, Zwaan CM, van den Heuvel-Eibrink M. Pediatric AML. From biology to clinical management. J Clin Med. 2015; 4: 127–149. de RooijJD ZwaanCM van den Heuvel-EibrinkM Pediatric AML. From biology to clinical management J Clin Med. 2015 4 127 149 10.3390/jcm4010127447024426237023 Search in Google Scholar

[2] Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer. 1995; 75: 2186–2195. GurneyJG SeversonRK DavisS RobisonLL Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type Cancer. 1995 75 2186 2195 10.1002/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F Search in Google Scholar

[3] Wang Y, Huang J, Rong L, Wu P, Kang M, Zhang X, Lu Q, Fang Y. Impact of age on the survival of pediatric leukemia: An analysis of 15083 children in the SEER database. Oncotarget. 2016; 7: 83767–83774. WangY HuangJ RongL WuP KangM ZhangX LuQ FangY Impact of age on the survival of pediatric leukemia: An analysis of 15083 children in the SEER database Oncotarget. 2016 7 83767 83774 10.18632/oncotarget.11765 Search in Google Scholar

[4] Ilhan G, Karakus S, Andic N. Risk factors and primary prevention of acute leukemia. Asian Pac J Cancer Prev. 2006; 7: 515–517. IlhanG KarakusS AndicN Risk factors and primary prevention of acute leukemia Asian Pac J Cancer Prev. 2006 7 515 517 Search in Google Scholar

[5] Raje N, Snyder BL, Hill DA, Streicher JL, Sullivan KE. Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment. Ann Allergy Asthma Immunol. 2018; 120: 537–538.e531. RajeN SnyderBL HillDA StreicherJL SullivanKE Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment Ann Allergy Asthma Immunol. 2018 120 537 538.e531 10.1016/j.anai.2017.12.023 Search in Google Scholar

[6] Ramadan SM, Fouad TM, Summa V, Hasan SKh, Lo-Coco F. Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica. 2012; 97: 805–817. RamadanSM FouadTM SummaV HasanSKh Lo-CocoF Acute myeloid leukemia developing in patients with autoimmune diseases Haematologica. 2012 97 805 817 10.3324/haematol.2011.056283 Search in Google Scholar

[7] Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, et al. Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010; 115: 453–474. DöhnerH EsteyEH AmadoriS AppelbaumFR BüchnerT BurnettAK DombretH FenauxP GrimwadeD LarsonRA Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet Blood. 2010 115 453 474 10.1182/blood-2009-07-235358 Search in Google Scholar

[8] Gocho Y, Yang JJ. Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia. Blood. 2019; 134: 793–797. GochoY YangJJ Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia Blood. 2019 134 793 797 10.1182/blood.2018852400 Search in Google Scholar

[9] Bartenhagen C, Fischer U, Korn K, Pfister SM, Gombert M, Chen C, Okpanyi V, Hauer J, Rinaldi A, Bourquin JP, et al. Infection as a cause of childhood leukemia: Virus detection employing whole genome sequencing. Haematologica. 2017; 102: e179–e183. BartenhagenC FischerU KornK PfisterSM GombertM ChenC OkpanyiV HauerJ RinaldiA BourquinJP Infection as a cause of childhood leukemia: Virus detection employing whole genome sequencing Haematologica. 2017 102 e179 e183 10.3324/haematol.2016.155382 Search in Google Scholar

[10] Szczepański T, Harrison CJ, van Dongen JJ. Genetic aberrations in paediatric acute leukaemias and implications for management of patients. Lancet Oncol. 2010; 11: 880–889. SzczepańskiT HarrisonCJ van DongenJJ Genetic aberrations in paediatric acute leukaemias and implications for management of patients Lancet Oncol. 2010 11 880 889 10.1016/S1470-2045(09)70369-9 Search in Google Scholar

[11] Vargas-Rondón N, Villegas VE, Rondón-Lagos M. The role of chromosomal instability in cancer and therapeutic responses. Cancers. 2017; 10: 4. Vargas-RondónN VillegasVE Rondón-LagosM The role of chromosomal instability in cancer and therapeutic responses Cancers. 2017 10 4 10.3390/cancers10010004 Search in Google Scholar

[12] Gordon DJ, Resio B, Pellman D. Causes and consequences of aneuploidy in cancer. Nat Rev Genet. 2012; 13: 189–203. GordonDJ ResioB PellmanD Causes and consequences of aneuploidy in cancer Nat Rev Genet. 2012 13 189 203 10.1038/nrg312322269907 Search in Google Scholar

[13] Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr Biol. 2010; 20: R285–R295. ThompsonSL BakhoumSF ComptonDA Mechanisms of chromosomal instability Curr Biol. 2010 20 R285 R295 10.1016/j.cub.2010.01.034378136520334839 Search in Google Scholar

[14] Zasadil LM, Britigan EM, Weaver BA. 2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. Semin Cell Dev Biol. 2013; 24: 370–379. ZasadilLM BritiganEM WeaverBA 2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells Semin Cell Dev Biol. 2013 24 370 379 10.1016/j.semcdb.2013.02.001373681923416057 Search in Google Scholar

[15] Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976; 33: 451–458. BennettJM CatovskyD DanielMT FlandrinG GaltonDA GralnickHR SultanC Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group Br J Haematol. 1976 33 451 458 10.1111/j.1365-2141.1976.tb03563.x188440 Search in Google Scholar

[16] Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van’t Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995; 9: 1783–1786. BeneMC CastoldiG KnappW LudwigWD MatutesE OrfaoA van’t VeerMB Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL) Leukemia. 1995 9 1783 1786 Search in Google Scholar

[17] Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, Cheng C, Su X, Rubnitz JE, Basso G, et al. Early T-cell precursor leukaemia: A subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009; 10: 147–156. Coustan-SmithE MullighanCG OnciuM BehmFG RaimondiSC PeiD ChengC SuX RubnitzJE BassoG Early T-cell precursor leukaemia: A subtype of very high-risk acute lymphoblastic leukaemia Lancet Oncol. 2009 10 147 156 10.1016/S1470-2045(08)70314-0284024119147408 Search in Google Scholar

[18] Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127: 2375–2390. SwerdlowSH CampoE PileriSA HarrisNL SteinH SiebertR AdvaniR GhielminiM SallesGA ZelenetzAD JaffeES The 2016 revision of the World Health Organization classification of lymphoid neoplasms Blood. 2016 127 2375 2390 10.1182/blood-2016-01-643569487422026980727 Search in Google Scholar

[19] Jaffe ES, Barr PM, Smith SM. Understanding the new WHO classification of lymphoid malignancies: Why it's important and how it will affect practice. Am Soc Clin Oncol Educ Book. 2017; 37: 535–546. JaffeES BarrPM SmithSM Understanding the new WHO classification of lymphoid malignancies: Why it's important and how it will affect practice Am Soc Clin Oncol Educ Book. 2017 37 535 546 10.1200/EDBK_175437632453328561690 Search in Google Scholar

[20] Bain BJ, Béné MC. Morphological and immunophenotypic clues to the WHO categories of acute myeloid leukaemia. Acta Haematol. 2019; 141: 232–244. BainBJ BénéMC Morphological and immunophenotypic clues to the WHO categories of acute myeloid leukaemia Acta Haematol. 2019 141 232 244 10.1159/00049609730965338 Search in Google Scholar

[21] Derwich K, Lejman M, Taha J, Pastorczak A, Młynarski W, Styczyński J, Szczepański T. Standardy postępowania diagnostycznego w ostrej białaczce limfoblastycznej u dzieci. Rekomendacje Polskiego Towarzystwa Onkologii i Hematologii Dziecięcej. Przegl Pediatr. 2019; 48: 12–18. DerwichK LejmanM TahaJ PastorczakA MłynarskiW StyczyńskiJ SzczepańskiT Standardy postępowania diagnostycznego w ostrej białaczce limfoblastycznej u dzieci. Rekomendacje Polskiego Towarzystwa Onkologii i Hematologii Dziecięcej Przegl Pediatr. 2019 48 12 18 Search in Google Scholar

[22] Boettcher M, Joechner A, Li Z, Yang SF, Schlegel P. Development of CAR T cell therapy in children – a comprehensive overview. J Clin Med. 2022; 11: 2158. BoettcherM JoechnerA LiZ YangSF SchlegelP Development of CAR T cell therapy in children – a comprehensive overview J Clin Med. 2022 11 2158 10.3390/jcm11082158902469435456250 Search in Google Scholar

[23] Ceppi F, Duval M, Leclerc JM,. Laverdiere C, Delva YL, Cellot S, Teira P, Bittencourt H. Improvement of the outcome of relapsed or refractory acute lymphoblastic leukemia in children using a risk-based treatment strategy. PLoS One. 2016; 11: e0160310. CeppiF DuvalM LeclercJM LaverdiereC DelvaYL CellotS TeiraP BittencourtH Improvement of the outcome of relapsed or refractory acute lymphoblastic leukemia in children using a risk-based treatment strategy PLoS One. 2016 11 e0160310 10.1371/journal.pone.0160310502514627632202 Search in Google Scholar

[24] Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, et al. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: A therapeutic advances in childhood leukemia consortium study. J Clin Oncol. 2010; 28: 648–654. KoRH JiL BarnetteP BostromB HutchinsonR RaetzE SeibelNL TwistCJ EckrothE SpostoR Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: A therapeutic advances in childhood leukemia consortium study J Clin Oncol. 2010 28 648 654 10.1200/JCO.2009.22.2950281599919841326 Search in Google Scholar

[25] Sandahl JD, Kjeldsen E, Abrahamsson J, Ha SY, Heldrup J, Jahnukainen K, Jónsson OG, Lausen B, Palle J, Zeller B, et al. Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study. Genes Chromosomes Cancer. 2014; 53: 667–675. SandahlJD KjeldsenE AbrahamssonJ HaSY HeldrupJ JahnukainenK JónssonOG LausenB PalleJ ZellerB Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study Genes Chromosomes Cancer. 2014 53 667 675 10.1002/gcc.2217724753324 Search in Google Scholar

[26] Pastorczak A, Młynarski W, Szczepański T. Prognostic and therapeutic implications of genetic aberrations in childhood acute lymphoblastic leukemia. Hematologia. 2011; 2: 43–50. PastorczakA MłynarskiW SzczepańskiT Prognostic and therapeutic implications of genetic aberrations in childhood acute lymphoblastic leukemia Hematologia. 2011 2 43 50 Search in Google Scholar

[27] Paulsson K, Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2009; 48: 637–660. PaulssonK JohanssonB High hyperdiploid childhood acute lymphoblastic leukemia Genes Chromosomes Cancer. 2009 48 637 660 10.1002/gcc.2067119415723 Search in Google Scholar

[28] Paulsson K, Forestier E, Lilljebjörn H, Heldrup J, Behrendtz M, Young BD, Johansson B. Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 2010; 107: 21719–21724. PaulssonK ForestierE LilljebjörnH HeldrupJ BehrendtzM YoungBD JohanssonB Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia Proc Natl Acad Sci USA. 2010 107 21719 21724 10.1073/pnas.1006981107300312621098271 Search in Google Scholar

[29] Dastugue N, Suciu S, Plat G, Speleman F, Cavé H, Girard S, Bakkus M, Pagès MP, Yakouben K, Nelken B, et al. Hyperdiploidy with 58–66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results. Blood. 2013; 121: 2415–2423. DastugueN SuciuS PlatG SpelemanF CavéH GirardS BakkusM PagèsMP YakoubenK NelkenB Hyperdiploidy with 58–66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results Blood. 2013 121 2415 2423 10.1182/blood-2012-06-43768123321258 Search in Google Scholar

[30] Trueworthy R, Shuster J, Look T, Crist W, Borowitz M, Carroll A, Frankel L, Harris M, Wagner H, Haggard M. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol. 1992; 10: 606–613. TrueworthyR ShusterJ LookT CristW BorowitzM CarrollA FrankelL HarrisM WagnerH HaggardM Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study J Clin Oncol. 1992 10 606 613 10.1200/JCO.1992.10.4.6061548523 Search in Google Scholar

[31] Whitehead VM, Vuchich MJ, Cooley LD, Lauer SJ, Mahoney DH, Shuster JJ, Payment C, Koch PA, Akabutu JJ, Bowen T, et al. Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Leuk Lymphoma. 1998; 31: 507–519. WhiteheadVM VuchichMJ CooleyLD LauerSJ MahoneyDH ShusterJJ PaymentC KochPA AkabutuJJ BowenT Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: A Pediatric Oncology Group Study Leuk Lymphoma. 1998 31 507 519 10.3109/104281998090576109922041 Search in Google Scholar

[32] Carroll WL, Raetz EA. Building better therapy for children with acute lymphoblastic leukemia. Cancer Cell. 2005; 7: 289–291. CarrollWL RaetzEA Building better therapy for children with acute lymphoblastic leukemia Cancer Cell. 2005 7 289 291 10.1016/j.ccr.2005.04.00315837616 Search in Google Scholar

[33] Lustosa de Sousa DW, de Almeida Ferreira FV, Cavalcante Félix FH, de Oliveira Lopes MV. Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival. Rev Bras Hematol Hemoter. 2015; 37: 223–229. Lustosa de SousaDW de Almeida FerreiraFV Cavalcante FélixFH de Oliveira LopesMV Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival Rev Bras Hematol Hemoter. 2015 37 223 229 10.1016/j.bjhh.2015.03.009451971026190424 Search in Google Scholar

[34] Balwierz W, Czogała M, Pawińska-Wąsikowska K, Książek T, Bukowska-Strakova K, Czogała W, Szczepański T, Kałwak K, Styczyński J. Standardy postępowania diagnostycznego w ostrych białaczkach szpikowych i przewlekłej białaczce szpikowej u dzieci. Przegl Pediatr. 2019; 48: 23–32. BalwierzW CzogałaM Pawińska-WąsikowskaK KsiążekT Bukowska-StrakovaK CzogałaW SzczepańskiT KałwakK StyczyńskiJ Standardy postępowania diagnostycznego w ostrych białaczkach szpikowych i przewlekłej białaczce szpikowej u dzieci Przegl Pediatr. 2019 48 23 32 Search in Google Scholar

[35] Raimondi SC. Cytogenetics in acute leukemias. In: Pui CH, ed. Childhood Leukemias. New York: Cambrige University Press; 2006: 238–265. RaimondiSC Cytogenetics in acute leukemias In: PuiCH ed. Childhood Leukemias New York Cambrige University Press 2006 238 265 10.1017/CBO9780511471001.010 Search in Google Scholar

[36] Pierzyna-Świtała M, Sędek Ł, Mazur B. Significance of numerical chromosome abnormalities in children with acute leukaemias detected by flow cytometry. Pediatria Polska - Polish Journal of Paediatrics. 2018; 93: 396–402. Pierzyna-ŚwitałaM SędekŁ MazurB Significance of numerical chromosome abnormalities in children with acute leukaemias detected by flow cytometry Pediatria Polska - Polish Journal of Paediatrics. 2018 93 396 402 10.5114/polp.2018.80689 Search in Google Scholar

[37] Pui CH, Carroll AJ, Head D, Raimondi C, Shuster JJ, Crist WM, Link MP, Borowitz MJ, Behm FG, Land VJ. Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood. 1990; 76: 590–596. PuiCH CarrollAJ HeadD RaimondiC ShusterJJ CristWM LinkMP BorowitzMJ BehmFG LandVJ Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood Blood. 1990 76 590 596 10.1182/blood.V76.3.590.590 Search in Google Scholar

[38] Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR, Broadfield ZJ, Harris RL, Taylor KE, Gibson BE, et al. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood. 2003; 102: 2756–2762. MoormanAV RichardsSM MartineauM CheungKL RobinsonHM JalaliGR BroadfieldZJ HarrisRL TaylorKE GibsonBE Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia Blood. 2003 102 2756 2762 10.1182/blood-2003-04-112812829593 Search in Google Scholar

[39] Rachieru-Sourisseau P, Baranger L, Dastugue N, Robert A, Geneviève F, Kuhlein E, Chassevent A. DNA index in childhood acute lymphoblastic leukaemia: A karyotypic method to validate the flow cytometric measurement. Int J Lab Hematol. 2010; 32: 288–298. Rachieru-SourisseauP BarangerL DastugueN RobertA GenevièveF KuhleinE ChasseventA DNA index in childhood acute lymphoblastic leukaemia: A karyotypic method to validate the flow cytometric measurement Int J Lab Hematol. 2010 32 288 298 10.1111/j.1751-553X.2009.01189.x19793113 Search in Google Scholar

[40] Heerema NA, Nachman JB, Sather HN, Sensel MG, Lee MK, Hutchinson R, Lange BJ, Steinherz PG, Bostrom B, Gaynon PS, Uckun F. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. Blood. 1999; 94: 4036–4045. HeeremaNA NachmanJB SatherHN SenselMG LeeMK HutchinsonR LangeBJ SteinherzPG BostromB GaynonPS UckunF Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group Blood. 1999 94 4036 4045 Search in Google Scholar

[41] Moorman AV. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Blood Rev. 2012; 26: 123–135. MoormanAV The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia Blood Rev. 2012 26 123 135 10.1016/j.blre.2012.01.00122436535 Search in Google Scholar

[42] Blandin AT, Mühlematter D, Bougeon S, Gogniat C, Porter S, Beyer V, Parlier V, Beckmann JS, van Melle G, Jotterand M. Automated four-color interphase fluorescence in situ hybridization approach for the simultaneous detection of specific aneuploidies of diagnostic and prognostic significance in high hyperdiploid acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2008; 186: 69–77. BlandinAT MühlematterD BougeonS GogniatC PorterS BeyerV ParlierV BeckmannJS van MelleG JotterandM Automated four-color interphase fluorescence in situ hybridization approach for the simultaneous detection of specific aneuploidies of diagnostic and prognostic significance in high hyperdiploid acute lymphoblastic leukemia Cancer Genet Cytogenet. 2008 186 69 77 10.1016/j.cancergencyto.2008.06.00818940469 Search in Google Scholar

[43] Heerema NA, Raimondi SC, Anderson JR, Biegel J, Camitta BM, Cooley LD, Gaynon PS, Hirsch B, Magenis RE, McGavran L, et al. Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2007; 46: 684–693. HeeremaNA RaimondiSC AndersonJR BiegelJ CamittaBM CooleyLD GaynonPS HirschB MagenisRE McGavranL Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia Genes Chromosomes Cancer. 2007 46 684 693 10.1002/gcc.2045117431878 Search in Google Scholar

[44] Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, Payne-Turner D, Churchman M, Andersson A, Chen SC, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013; 45: 242–252. HolmfeldtL WeiL Diaz-FloresE WalshM ZhangJ DingL Payne-TurnerD ChurchmanM AnderssonA ChenSC The genomic landscape of hypodiploid acute lymphoblastic leukemia Nat Genet. 2013 45 242 252 10.1038/ng.2532391979323334668 Search in Google Scholar

[45] Zhang Y, Lu J, van den Berghe J, Lee SH. Increased incidence of spontaneous apoptosis in the bone marrow of hyperdiploid childhood acute lymphoblastic leukemia. Exp Hematol. 2002; 30: 333–339. ZhangY LuJ van den BergheJ LeeSH Increased incidence of spontaneous apoptosis in the bone marrow of hyperdiploid childhood acute lymphoblastic leukemia Exp Hematol. 2002 30 333 339 10.1016/S0301-472X(02)00771-3 Search in Google Scholar

[46] Raimondi SC, Zhou Y, Mathew S, Raimondi SC, Zhou Y, Mathew S, Shurtleff SA, Sandlund JT, Rivera GK, Behm FG, Pui CH. Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia. Cancer. 2003; 98: 2715–2722. RaimondiSC ZhouY MathewS RaimondiSC ZhouY MathewS ShurtleffSA SandlundJT RiveraGK BehmFG PuiCH Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia Cancer. 2003 98 2715 2722 10.1002/cncr.1184114669294 Search in Google Scholar

[47] Zaliova M, Hovorkova L, Vaskova M, Hrusak O, Stary J, Zuna J. Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16. Genes Chromosomes Cancer. 2016; 55: 727–737. ZaliovaM HovorkovaL VaskovaM HrusakO StaryJ ZunaJ Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16 Genes Chromosomes Cancer. 2016 55 727 737 10.1002/gcc.2237427163296 Search in Google Scholar

[48] Kubicka M, Mucha B, Soszyńska K, Skonieczna K, Rafińska B, Kołodziej B, Dębski R, Hus O, Styczyński J. Hiperdiplodia limfoblastów i jej związek z immunofenotypem w ostrej białaczce limfoblastycznej. Pediatria Polska. 2008; 82: 766–774. KubickaM MuchaB SoszyńskaK SkoniecznaK RafińskaB KołodziejB DębskiR HusO StyczyńskiJ Hiperdiplodia limfoblastów i jej związek z immunofenotypem w ostrej białaczce limfoblastycznej Pediatria Polska. 2008 82 766 774 10.1016/S0031-3939(07)70326-8 Search in Google Scholar

[49] Hrusák O, Porwit-MacDonald A. Antigen expression patterns reflecting genotype of acute leukemias. Leukemia. 2002; 16: 1233–1258. HrusákO Porwit-MacDonaldA Antigen expression patterns reflecting genotype of acute leukemias Leukemia. 2002 16 1233 1258 10.1038/sj.leu.240250412094248 Search in Google Scholar

[50] Djokic M, Björklund E, Blennow E, Mazur J, Söderhäll S, Porwit A. Over-expression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia. Haematologica. 2009; 94: 1016–1019. DjokicM BjörklundE BlennowE MazurJ SöderhällS PorwitA Over-expression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia Haematologica. 2009 94 1016 1019 10.3324/haematol.2008.000299270431419454491 Search in Google Scholar

[51] Muñoz L, Nomdedéu JF, López O, Carnicer MJ, Bellido M, Aventín A, Brunet S, Sierra J. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica. 2001; 86: 1261–1269. MuñozL NomdedéuJF LópezO CarnicerMJ BellidoM AventínA BrunetS SierraJ Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies Haematologica. 2001 86 1261 1269 Search in Google Scholar

[52] Harrison CJ, Moorman AV, Broadfield ZJ, Cheung KL, Harris RL, Reza Jalali G, Robinson HM, Barber KE, Richards SM, Mitchell CD, et al. Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. Br J Haematol. 2004; 125: 552–559. HarrisonCJ MoormanAV BroadfieldZJ CheungKL HarrisRL Reza JalaliG RobinsonHM BarberKE RichardsSM MitchellCD Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia Br J Haematol. 2004 125 552 559 10.1111/j.1365-2141.2004.04948.x15147369 Search in Google Scholar

[53] Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, Kinsey SE, Vora A, Mitchell CD, Harrison CJ. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: Results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol. 2010; 11: 429–438. MoormanAV EnsorHM RichardsSM ChiltonL SchwabC KinseySE VoraA MitchellCD HarrisonCJ Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: Results from the UK Medical Research Council ALL97/99 randomised trial Lancet Oncol. 2010 11 429 438 10.1016/S1470-2045(10)70066-820409752 Search in Google Scholar

[54] Nachman JB, Heerema NA, Sather H, Camitta B, Forestier E, Harrison CJ, Dastugue N, Schrappe M, Pui CH, Basso G, et al. Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood. 2007; 110: 1112–1115. NachmanJB HeeremaNA SatherH CamittaB ForestierE HarrisonCJ DastugueN SchrappeM PuiCH BassoG Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia Blood. 2007 110 1112 1115 10.1182/blood-2006-07-038299193989517473063 Search in Google Scholar

[55] Carroll AJ, Shago M, Mikhail FM, Raimondi SC, Hirsch BA, Loh ML, Raetz EA, Borowitz MJ, Wood BL, Maloney KW, et al. Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group. Cancer Genet. 2019; 238: 62–68. CarrollAJ ShagoM MikhailFM RaimondiSC HirschBA LohML RaetzEA BorowitzMJ WoodBL MaloneyKW Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group Cancer Genet. 2019 238 62 68 10.1016/j.cancergen.2019.07.009676869331425927 Search in Google Scholar

[56] Groeneveld-Krentz S, Schroeder MP, Reiter M, Pogodzinski MJ, Pimentel-Gutiérrez HJ, Vagkopoulou R, Hof J, Chen-Santel C, Nebral K, Bradtke J, et al. Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: Clinical importance of detecting a hypodiploid origin of relapse. Br J Haematol. 2019; 185: 266–283. Groeneveld-KrentzS SchroederMP ReiterM PogodzinskiMJ Pimentel-GutiérrezHJ VagkopoulouR HofJ Chen-SantelC NebralK BradtkeJ Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: Clinical importance of detecting a hypodiploid origin of relapse Br J Haematol. 2019 185 266 283 10.1111/bjh.1577030714092 Search in Google Scholar

[57] Comeaux EQ, Mullighan CG. Mutations in hypodiploid acute lymphoblastic leukemia. Cold Spring Harb Perspect Med. 2017; 7: a026286. ComeauxEQ MullighanCG Mutations in hypodiploid acute lymphoblastic leukemia Cold Spring Harb Perspect Med. 2017 7 a026286 10.1101/cshperspect.a026286533424928003275 Search in Google Scholar

[58] Creutzig U, Reinhardt D, Diekamp S, Dworzak M, Stary J, Zimmermann M. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia. 2005; 19: 1355–1360. CreutzigU ReinhardtD DiekampS DworzakM StaryJ ZimmermannM AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity Leukemia. 2005 19 1355 1360 10.1038/sj.leu.240381415920490 Search in Google Scholar

[59] Lazarevic V, Rosso A, Juliusson G, Antunovic P, Rangert-Derolf Å, Lehmann S, Möllgård L, Uggla B, Wennström L, Wahlin A, et al. Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia. Am J Hematol. 2015; 90: 800–805. LazarevicV RossoA JuliussonG AntunovicP Rangert-DerolfÅ LehmannS MöllgårdL UgglaB WennströmL WahlinA Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia Am J Hematol. 2015 90 800 805 10.1002/ajh.2409126088289 Search in Google Scholar

[60] Chilton L, Hills RK, Harrison CJ, Burnett AK, Grimwade D, Moorman AV. Hyperdiploidy with 49–65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcome. Leukemia. 2014; 28: 321–328. ChiltonL HillsRK HarrisonCJ BurnettAK GrimwadeD MoormanAV Hyperdiploidy with 49–65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcome Leukemia. 2014 28 321 328 10.1038/leu.2013.19823812419 Search in Google Scholar

[61] Vidriales MB, Orfao A, López-Berges MC, González M, López-Macedo A, Ciudad J, López A, Cañizo MC, Garcia MA, San Miguel JF. DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markers. Cytometry. 1995; 22: 22–25. VidrialesMB OrfaoA López-BergesMC GonzálezM López-MacedoA CiudadJ LópezA CañizoMC GarciaMA San MiguelJF DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markers Cytometry. 1995 22 22 25 10.1002/cyto.9902201057587729 Search in Google Scholar